Document is current
Any future updates will be listed below
-
Authors
Orvain, Corentin https://orcid.org/0000-0002-8717-0824
Bertoli, Sarah https://orcid.org/0000-0003-1084-2781
Peterlin, Pierre
Desbrosses, Yohann
Dumas, Pierre-Yves
Iat, Alexandre https://orcid.org/0009-0009-5370-9025
Hospital, Marie-Anne
Carre, Martin
Tavernier, Emmanuelle https://orcid.org/0000-0002-1447-8721
Riou, Jérémie https://orcid.org/0000-0002-7056-9257
Bouvier, Anne https://orcid.org/0000-0003-0140-5360
Bidet, Audrey https://orcid.org/0000-0003-0992-8377
Tondeur, Sylvie
Renosi, Florian https://orcid.org/0000-0002-6149-0547
Mozziconacci, Marie-Joelle
Flandrin-Gresta, Pascale
Dadone-Montaudié, Bérengère
Delabesse, Eric https://orcid.org/0000-0002-0928-0753
Pigneux, Arnaud https://orcid.org/0000-0001-5479-0261
Hunault-Berger, Mathilde https://orcid.org/0000-0001-7777-5216
Recher, Christian
- License Information
-
More Information
Article History
Received: 3 April 2024
Revised: 24 June 2024
Accepted: 1 July 2024
First Online: 17 July 2024
Competing interests
: Employment or Leadership Position: none; Consultant or Advisory Role: Pierre Peterlin, Abbvie, BMS and Servier; Christian Récher, Abbvie, Amgen, Astellas, BMS, Boehringer, Jazz Pharmaceuticals, and Servier; Stock Ownership: none; Honoraria: none; Research Funding: Pierre Peterlin, Astellas and Jazz Pharmaceuticals; Christian Récher, Abbvie, Amgen, Astellas, BMS, Iqvia, and Jazz Pharmaceuticals; Expert Testimony: none; Patents: none; Other Remuneration: none.
: This study was led according to the Declaration of Helsinki. This study was approved by an institutional Research Ethics Board (Angers University Hospital Ethics Committee # 2021-120). Because of the retrospective non-interventional nature of our study, informed consent was waived according to national regulations.
